How to Use Kliovance

How to Take Kliovance: Step-by-Step Usage Guide

1. Set up the calendar pack: Rotate the inner disc until the day of the week aligns with the plastic tab. Break the tab to access the first tablet.
2. Take the first tablet: Tip out the tablet for the appropriate day. Swallow it whole with water. Do not chew.
3. Daily routine: Each day, rotate the transparent dial clockwise by one space (arrow direction) and take the next tablet. Always take one tablet at roughly the same time each day.
4. Continue without interruption: When you finish all 28 tablets, start a new pack the next day. There is no tablet‑free break or placebo tablets.
5. Starting point: If you are new to HRT, you may start on any convenient day. If you are switching from a sequential HRT (one that causes a monthly bleed), start Kliovance after that withdrawal bleed ends.

Dosage Guide for Kliovance

The standard dose is one tablet once daily. Each tablet contains 1 mg estradiol (as estradiol hemihydrate) and 0.5 mg norethisterone acetate. Your doctor will prescribe the lowest effective dose for the shortest duration necessary based on your symptoms and risk profile. Do not alter the dose without medical advice.

• If you miss a dose: Take it as soon as you remember, provided it is within 12 hours of your usual time. If more than 12 hours have passed, skip the missed dose and continue with the next tablet at your regular time. Never take a double dose to make up for a missed one.
• If you take too many tablets: Overdose may cause nausea, vomiting, or breast tenderness. Contact your doctor or pharmacist for advice.
• Duration of use: Regular review with your doctor (at least annually) is essential to reassess the need for continuing treatment.

Who Should Use Kliovance (Indications)

Kliovance is indicated for postmenopausal women with at least 12 months since their last natural period and who have not had their womb removed (uterus intact). It is used for:

• Relief of menopausal symptoms: Hot flushes, night sweats, mood disturbances, and urogenital atrophy that significantly affect quality of life.
• Prevention of osteoporosis: In women at high risk of fractures who cannot take other bone‑protective medicines.

It is suitable only when the benefits outweigh the risks, as assessed by a healthcare professional.

Who Should Not Use Kliovance (Contraindications)

Do not take Kliovance if any of the following applies to you. If you are unsure, ask your doctor before starting.

• Breast cancer, or suspected breast cancer.
• Oestrogen‑sensitive cancer (e.g., endometrial cancer) or suspicion of it.
• Any unexplained vaginal bleeding.
• Untreated endometrial hyperplasia.
• Current or past blood clot in a vein (deep vein thrombosis, pulmonary embolism).
• Known blood clotting disorder (e.g., protein C, protein S deficiency).
• Recent heart attack, stroke, or angina caused by arterial clots.
• Liver disease with abnormal liver function tests.
• Rare inherited blood disorder: porphyria.
• Allergy (hypersensitivity) to estradiol, norethisterone, or any excipient (including lactose).

Taking Kliovance with Food and Without Food

Kliovance tablets can be taken with or without food. Food does not significantly affect absorption. However, taking the tablet at the same time each day (e.g., with breakfast or after dinner) can help establish a routine and reduce the chance of forgetting a dose. If you experience mild nausea, taking it with a meal may improve tolerance.

Avoid grapefruit juice while on HRT, as it may interfere with hormone metabolism, though no specific interaction is documented for Kliovance.

Special Conditions and Considerations

Inform your doctor if you have any of the following conditions before starting Kliovance, as they may require closer monitoring or influence the decision to prescribe:

• Fibroids or endometriosis – may worsen temporarily.
• High blood pressure – monitor regularly.
• Diabetes – HRT can affect glucose tolerance.
• Liver or gallbladder disease – including history of gallstones.
• Migraine or severe headaches – frequency may increase.
• Systemic lupus erythematosus (SLE) – may flare.
• Epilepsy, asthma, otosclerosis – may be affected.
• High triglycerides – risk of pancreatitis.
• Hereditary angioedema – HRT may trigger attacks.
• Lactose intolerance – each tablet contains 71.6 mg lactose monohydrate; unsuitable for patients with rare galactose intolerance, Lapp lactase deficiency, or glucose‑galactose malabsorption.

Surgery: If you are scheduled for surgery (especially orthopaedic or abdominal), you should usually stop Kliovance 4‑6 weeks beforehand to reduce the risk of blood clots. Ask your surgeon or doctor when to restart.

Pregnancy and Breast‑feeding

Pregnancy: Kliovance is intended only for postmenopausal women and should not be used during pregnancy. If you become pregnant while taking it, stop the tablets immediately and inform your doctor.

Breast‑feeding: Do not take Kliovance while breast‑feeding, as hormones can pass into breast milk and may affect the infant or milk production.

Contraception note: If you are less than 12 months since your last period or are under 50, you may still be fertile and should use additional non‑hormonal contraception (e.g., condoms). Speak to your doctor for personalised advice.

Kliovance Usage FAQs

Need Kliovance with Personalised HRT Support?

If you are considering continuous combined HRT, our UK-registered doctors can assess your suitability, provide a prescription, and guide you through correct usage and monitoring.

Secure Prescription & Next-Day Delivery

GPhC‑registered pharmacy | Discreet packaging | Ongoing clinical follow‑up